Step Beyond the Scale: How NewBeauty is Leading the GLP-1 Conversation — Mike Glaicar
About this episode
Dr. Randi discusses with NewBeauty CEO Mike Glaicar the impact of GLP-1 medications on aesthetics and patient expectations.
Over the past year, prescription weight loss medications have reshaped the trajectory of the aesthetics industry. What began as a breakthrough in metabolic health has rapidly expanded into something much bigger, influencing facial aging, body composition, longevity, and the way aesthetic clinics support their patients. In this episode, Dr. Randi sits down with NewBeauty CEO Mike Glaicar to discuss how the rise of GLP-1 medications is changing the landscape of beauty, wellness, and patient expectations. As millions of people begin their weight loss journeys, many are encountering unexpected aesthetic changes such as facial volume loss, skin laxity, and hair thinning, creating a growing need for guidance and education. That need led to the creation of Step Beyond the Scale, a NewBeauty platform designed to bring credible, expert-backed insight to the GLP-1 conversation. Rather than relying on fragmented social media advice or limited pharmaceutical messaging, the platform brings together leading experts to help patients better understand and navigate these changes. In this conversation, they explore: • The aesthetic changes patients are experiencing during rapid weight loss • Why…
More episodes of The Dr. Randi Show
- Peptides Under the Microscope | Special Report — Sarah Morgan
- In the Spotlight: Dr. Randi
- Beyond Beauty: Where Aesthetics Meets Longevity — Anthony Serhan
- K-Beauty: What’s Really Driving the Trend — Liah Yoo
- NAD: The Skincare Shift No One Saw Coming — Melisse Shaban
- The One-Hour Facelift: Inside the RE•LIFT™ Revolution — Dr. Adam Summers
Explore listener stats, chart rankings, contacts and more on the The Dr. Randi Show podcast page.